Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dayer

Showing results (221-230 of 283) with videos related to

Pageof 29
Sort By:
Transplantation|November 15, 1994
Plasma levels of tumor necrosis factor (TNF) and soluble TNF receptors in kidney transplant recipientsS E Dörge, P Roux-Lombard, J M Dayer, et al.
The Journal of Investigative Dermatology|June 1, 1989
Localization and characterization of the interleukin 1 immunoreactive pool (IL-1 alpha and beta forms) in normal human epidermisL Didierjean, D Salomon, Y Mérot, et al.
European Journal of Biochemistry|June 15, 1987
Purification and characterization of human interleukin-1 alpha produced in Escherichia coliP Wingfield, M Payton, P Graber, et al.
Blood|April 6, 2001
Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytesN Hyka, J M Dayer, C Modoux, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1979
Parathyroid hormone inhibitors: comparison of biological activity in bone- and skin-derived tissueS R Goldring, J E Mahaffey, M Rosenblatt, et al.
European Journal of Immunology|August 15, 2009
Soluble TNF-alpha but not transmembrane TNF-alpha sensitizes T cells for enhanced activation-induced cell deathStefan Müller, Silvia Rihs, Johanna M Dayer Schneider, et al.
British Dental Journal|January 23, 2016
Guidelines on prophylaxis to prevent infective endocarditisM H Thornhill, M Dayer, P B Lockhart, et al.
Rheumatology (Oxford, England)|January 2, 2003
The active metabolite of leflunomide, A77 1726, inhibits the production of prostaglandin E(2), matrix metalloproteinase 1 and interleukin 6 in human fibroblast-like synoviocytesD Burger, N Begué-Pastor, S Benavent, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|August 3, 1999
Effects of IL-6 and its soluble receptor on proteoglycan synthesis and NO release by human articular chondrocytes: comparison with IL-1. Modulation by dexamethasoneP A Guerne, A Desgeorges, J M Jaspar, et al.
British Dental Journal|August 13, 2016
A change in the NICE guidelines on antibiotic prophylaxisM H Thornhill, M Dayer, P B Lockhart, et al.
Pageof 29

Showing results (221-230 of 283) with videos related to

Sort By:
Pageof 29
Transplantation|November 15, 1994
Plasma levels of tumor necrosis factor (TNF) and soluble TNF receptors in kidney transplant recipientsS E Dörge, P Roux-Lombard, J M Dayer, et al.
The Journal of Investigative Dermatology|June 1, 1989
Localization and characterization of the interleukin 1 immunoreactive pool (IL-1 alpha and beta forms) in normal human epidermisL Didierjean, D Salomon, Y Mérot, et al.
European Journal of Biochemistry|June 15, 1987
Purification and characterization of human interleukin-1 alpha produced in Escherichia coliP Wingfield, M Payton, P Graber, et al.
Blood|April 6, 2001
Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytesN Hyka, J M Dayer, C Modoux, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1979
Parathyroid hormone inhibitors: comparison of biological activity in bone- and skin-derived tissueS R Goldring, J E Mahaffey, M Rosenblatt, et al.
European Journal of Immunology|August 15, 2009
Soluble TNF-alpha but not transmembrane TNF-alpha sensitizes T cells for enhanced activation-induced cell deathStefan Müller, Silvia Rihs, Johanna M Dayer Schneider, et al.
British Dental Journal|January 23, 2016
Guidelines on prophylaxis to prevent infective endocarditisM H Thornhill, M Dayer, P B Lockhart, et al.
Rheumatology (Oxford, England)|January 2, 2003
The active metabolite of leflunomide, A77 1726, inhibits the production of prostaglandin E(2), matrix metalloproteinase 1 and interleukin 6 in human fibroblast-like synoviocytesD Burger, N Begué-Pastor, S Benavent, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|August 3, 1999
Effects of IL-6 and its soluble receptor on proteoglycan synthesis and NO release by human articular chondrocytes: comparison with IL-1. Modulation by dexamethasoneP A Guerne, A Desgeorges, J M Jaspar, et al.
British Dental Journal|August 13, 2016
A change in the NICE guidelines on antibiotic prophylaxisM H Thornhill, M Dayer, P B Lockhart, et al.
Pageof 29